Friday, July 17, 2026

Controversial Recordings Spark Outrage in Oh Yoanna’s Death Investigation

Allegations of workplace bullying surround the tragic death of weathercaster Oh Yoanna, raising serious concerns and prompting investigations.

Trump Delays China Visit: What This Means for North Korea Talks in April?

Trump postpones China visit amid Middle East crisis, impacting U.S.-North Korea dialogue hopes, complicating South Korea's strategy.

Chinese Influencer’s Anti-Korean Statements Cause Online Uproar

Chinese influencer Zhang Yu'an, who is well-known...

Tag: PARP inhibitors

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Next-Gen Cancer Drug Nesuparib: How It Outperforms Olaparib in SCLC and Pancreatic Cancer

Onconic Therapeutics will present Nesuparib research at AACR 2026, showcasing its potential for various cancers and overcoming PARP inhibitor limitations.

New Hope for Solid Tumors? Korean Biotech Starts Phase 1 Trial of Targeted Drug

Digmbio secures 12 billion KRW for clinical trials of cancer drug DM5167 and advances treatment for degenerative brain diseases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.